542 results on '"Kornfeld, Hardy"'
Search Results
2. Lung function and collagen 1a levels are associated with changes in 6 min walk test distance during treatment of TB among HIV-infected adults: a prospective cohort study
3. A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction
4. The sound of silent RNA in tuberculosis and the lncRNA role on infection
5. Effect of prediabetes on tuberculosis treatment outcomes: A study from South India
6. Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment
7. Inflammatory profiles in sputum and blood of people with TB with and without HIV coinfection
8. Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection— a Multicenter Prospective Cohort Analysis
9. Sirtuin Deacetylases: Linking Mycobacterial Infection and Host Metabolism
10. Metformin: A Leading HDT Candidate for TB
11. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
12. The sound of silent RNA in Tuberculosis and the lncRNA role on infection
13. 1953. Impact of Baseline Nutritional Status on Tuberculosis Severity in India: a multicenter prospective cohort analysis
14. Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity
15. EFEITOS DA METFORMINA NO PERFIL INFLAMATÓRIO EM PACIENTES COM TUBERCULOSE E DIABETES TIPO 2
16. “The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design” – Meeting report
17. Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis.
18. Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis
19. Neutrophil-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis
20. Metformin: A Leading HDT Candidate for TB
21. Sirtuin Deacetylases: Linking Mycobacterial Infection and Host Metabolism
22. Empirical treatment with non-anti-tuberculosis antibiotics decreased microbiological detection in cervical tuberculous lymphadenitis
23. Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis
24. Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits
25. Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis
26. Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages From Diabetic Mice
27. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
28. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis
29. Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment
30. A Chemoattractant Cytokine Associated with Granulomas in Tuberculosis and Silicosis
31. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis
32. High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study
33. Bacillary replication and macrophage necrosis are determinants of neutrophil recruitment in tuberculosis
34. Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis
35. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
36. Indicators for prediction of Mycobacterium tuberculosis positivity detected with bronchoalveolar lavage fluid
37. Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis
38. Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection
39. Interleukin 16
40. Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India
41. Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure
42. Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study
43. Enhancement of Antimycobacterial Activity of Macrophages by Stabilization of Inner Mitochondrial Membrane Potential
44. Immunome-derived Epitope-driven Vaccines (ID-EDV) Protect against Viral or Bacterial Challenge in Humanized Mice
45. Cross-Reactivity to Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus and Molecular Cloning of Simian T-Cell Lymphotropic Virus Type III from African Green Monkeys
46. Molecular and Functional Analysis of a Lymphocyte Chemoattractant Factor: Association of Biologic Function with CD4 Expression
47. Additional file 1 of Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis
48. Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India
49. Sirtuin 3 Downregulation in Mycobacterium tuberculosis -Infected Macrophages Reprograms Mitochondrial Metabolism and Promotes Cell Death
50. Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.